Basic Information
VIS ID
TVIS10018847
Fusion event
HBV-chr10 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1806
Integrated sequence
ACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGC| |ACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGG
Host Sequence
Chromosome
chr10
Cytoband
p12.2
Reference genome
End
22619403/22330474 (Hg38)
Location type
Exon
Target gene
miRNAs that regulate target gene
hsa-mir-200c-3p ; hsa-mir-16-5p ; hsa-mir-15a-5p ; hsa-mir-128-3p ; hsa-mir-302b-3p ; hsa-mir-203a-3p ; hsa-mir-708-5p ; hsa-mir-200b-3p ; hsa-mir-194-5p ; hsa-mir-218-5p ; hsa-let-7g-5p ; hsa-mir-33a-5p ; hsa-mir-106b-3p ; hsa-mir-27a-3p ; hsa-mir-544a ; hsa-mir-494-3p ; hsa-mir-495-3p ; hsa-mir-300 ; hsa-mir-30e-5p ; hsa-mir-302a-3p ; hsa-mir-183-5p ; hsa-mir-379-3p ; hsa-mir-380-3p ; hsa-mir-411-3p ; hsa-mir-4495 ; hsa-mir-379-3p ; hsa-mir-380-3p ; hsa-mir-411-3p ; hsa-mir-4495 ; hsa-mir-559 ; hsa-mir-548b-5p ; hsa-mir-548a-5p ; hsa-mir-548c-5p ; hsa-mir-548d-5p ; hsa-mir-548j-5p ; hsa-mir-548n ; hsa-mir-548h-5p ; hsa-mir-548i ; hsa-mir-548w ; hsa-mir-548y ; hsa-mir-548o-5p ; hsa-mir-548ab ; hsa-mir-548ad-5p ; hsa-mir-548ae-5p ; hsa-mir-548ak ; hsa-mir-548am-5p ; hsa-mir-548ap-5p ; hsa-mir-548aq-5p ; hsa-mir-548ar-5p ; hsa-mir-548as-5p ; hsa-mir-548au-5p ; hsa-mir-548ay-5p ; hsa-mir-548bb-5p ; hsa-mir-559 ; hsa-mir-548b-5p ; hsa-mir-548a-5p ; hsa-mir-548c-5p ; hsa-mir-548d-5p ; hsa-mir-548j-5p ; hsa-mir-548n ; hsa-mir-548h-5p ; hsa-mir-548i ; hsa-mir-548w ; hsa-mir-548y ; hsa-mir-548o-5p ; hsa-mir-548ab ; hsa-mir-548ad-5p ; hsa-mir-548ae-5p ; hsa-mir-548ak ; hsa-mir-548am-5p ; hsa-mir-548ap-5p ; hsa-mir-548aq-5p ; hsa-mir-548ar-5p ; hsa-mir-548as-5p ; hsa-mir-548au-5p ; hsa-mir-548ay-5p ; hsa-mir-548bb-5p ; hsa-mir-580-5p ; hsa-mir-3120-3p ; hsa-mir-3942-5p ; hsa-mir-4703-5p ; hsa-mir-580-5p ; hsa-mir-3120-3p ; hsa-mir-3942-5p ; hsa-mir-4703-5p ; hsa-mir-376c-3p ; hsa-mir-320a ; hsa-mir-586 ; hsa-mir-586 ; hsa-mir-452-5p ; hsa-mir-487b-3p ; hsa-mir-548t-5p ; hsa-mir-548az-5p ; hsa-mir-548t-5p ; hsa-mir-548az-5p ; hsa-mir-195-3p ; hsa-mir-153-5p ; hsa-mir-16-2-3p ; hsa-mir-4666a-3p ; hsa-mir-338-5p ; hsa-mir-153-5p ; hsa-mir-195-3p ; hsa-mir-16-2-3p ; hsa-mir-4666a-3p ; hsa-mir-338-5p ; hsa-mir-15a-3p ; hsa-mir-192-5p ; hsa-mir-21-5p ; hsa-mir-3622b-5p ; hsa-mir-200c-5p ; hsa-mir-128-1-5p
Nearest miRNA
hsa-mir-1265/Upstream/833828; hsa-mir-107/Downstream/1945211;
Nearest cancer related gene
BMI1(OG, No orient, 0)
Upstream sequence
TTAATTACAGAAGGAAGAAAAAATCTATTAAGCAACAGCACAATAATAGACATCCCCCAAAATGACCATAATCCCCAAATTAAAAAGGATCCAGACAATT
Downstream sequence
TATACTTTTCTCCAGTAATACATGTTTACTTTAAAGATTGTTGCAGTGAAGAAAAACCTTTAACTGAGAAATATGGAAACCGTCTTAATTTTCCATTGGC
Target sequence
CTTTA
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate